Topics

Massive genetic study reveals new Alzheimer’s risk genes, linking immune system dysfunction to brain degeneration—offering hope for earlier detection, better treatments, and deeper understanding of disease mechanisms.

KAIST researchers create a method to find and restore key genes in disrupted cellular networks, offering potential for cancer treatments, drug development, and personalized medicine through precise control.

UW–Madison researchers identify genes that block CRISPR success, offering a roadmap for safer gene therapy—particularly for inherited eye diseases.

The trial activates three genes to partially reprogram aged cells in an effort to regenerate damaged optic nerve neurons in glaucoma patients.